It is well known that wild-type isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2, hereafter collectively referred to as IDH) and 1p19q non-deletion are two important genetic events in gliomas closely associated with rapid progression and high recurrence (14). This evidence concerns the gene IDH1 and central nervous system cancer.